definiens: means, on a Licensed Product - by - Licensed Product basis, the period commencing on the First Commercial Sale of the Lice nsed Product in the Territory and expiring upon the later of : ( a ) expiration or abandonment of the last Valid Claim of the Licensor Patents which cove rs the Commercialization of such Licensed Product in t he Territory, or ( b ) the earlier of ( x ) the time wh en Generic Competitors to the Licensed Product have ac hieved [ * * * ] percent ( [ * * * ] % ) or more market share in the Territory based on unit volume, or ( y ) ten ( 10 ) years following the date of First Commerc ial Sale of the Licensed Product in the Territory . means, with respect to any Licensed Product being sold in the Territory, one o r more Generic Drugs, where a Generic Drug is, with respect to any Licensed Product, a generic pharmace utical product ( a ) sold under a marketing authorization granted by a Governmental Authority t o a Third Party ( who is not a licensee or sublicens ee of Knight or otherwise authorized by Knight to sell such product ), ( b ) that contains the same Compound or Compounds as the relevant Licensed Product as it s active pharmaceutical ingredient(s ) and ( c ) is approved in reliance on a prior Regulatory Approval of a Licensed Product granted to Licensor, Knight or an Affiliate or sublicensee of Licensor or Knigh t by the applicable Governmental Authority . [ * * * ] percent ( [ * * * ] % ) or more market share means that th e sales of all such Generic Drugs in the Territory equal or exceed, on a unit volume basis, [ * * * ] perc ent ( [ * * * ] % ) of the total combined unit sales of th e Licensed Product and all such Generic Drugs in any Calendar Quarter